Gastric cancer remains a major global health challenge, and therapeutic resistance continues to limit the effectiveness of existing HER2-targeted treatments. A research team from Jiangsu University has developed a bispecific cellular nanovesicle platform that simultaneously targets CD16-positive natural killer (NK) cells and HER2-positive gastric cancer cells. The engineered nanovesicles enhance NK cell recruitment, activation, cytokine secretion, and tumor-killing activity, providing a promising strategy for next-generation cancer immunotherapy.

In a study of 54 adults with sleep disturbances and mild cognitive impairments (MCI), two hallmarks of early dementia, participants taking at least 5,000 IU of vitamin D daily showed better cognitive function compared to those who didn’t. The study, recently published in Sleep Medicine, found that participants who reported taking 5,000 IU or more of vitamin D daily scored more than 13% higher on the Montreal Cognitive Assessment (MoCA), even after accounting for other factors. A screening tool to detect risk of developing dementia, MoCA is widely used to assess memory and thinking skills. In this study, lower daily doses of vitamin D were not associated with higher cognitive scores.

BUFFALO, NY – September 28, 2026 – A new editorial was published in Volume 17 of Oncotarget on September 23, 2026, titled “Gut feeling: Microbes at the heart of cancer therapy.” 

The development of treatment resistance is one of the key challenges in modern cancer and antibiotic therapy. New therapeutic approaches aim to curb the spread of resistance through the targeted timing of treatment cycles. Researchers at the Max-Planck-Zentrum für Physik und Medizin (MPZPM) have now demonstrated how a deeper understanding of the physical processes occurring in growing tumors and microbial biofilms can contribute to the success of “evolution-based” therapies.

Wiley announces the launch of two new journals, Advanced Medicine and Advanced Healthy Aging, the latest additions to its expanding Advanced Portfolio.

A systematic review and meta-analysis of 14 studies involving 7,663 patients reveals that 40% of people with chronic pancreatitis (CP) develop exocrine pancreatic insufficiency (EPI). Smoking is identified as a significant risk factor, while diagnostic method strongly influences prevalence estimates—underscoring the urgent need for standardized EPI screening and early intervention.